Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer

被引:56
作者
Segelman, J. [1 ]
Akre, O. [2 ]
Gustafsson, U. O. [3 ]
Bottai, M. [4 ]
Martling, A. [1 ]
机构
[1] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[2] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden
[3] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Stockholm, Sweden
[4] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden
关键词
Colorectal cancer; peritoneal carcinomatosis; individual risk; INTRAPERITONEAL CHEMOTHERAPY; SYSTEMIC CHEMOTHERAPY; SURVIVAL; SURGERY; RECURRENCE; ORIGIN; CYTOREDUCTION; NOMOGRAM; CT;
D O I
10.1111/codi.12552
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimThe purpose of the study was to develop a tool for predicting the individual risk of metachronous peritoneal carcinomatosis after surgery for non-metastatic colorectal cancer. MethodIndependent predictors for metachronous colorectal carcinomatosis have previously been identified using a population-based database. Predictive models for colon and rectal cancer were developed from these data. The predictive models were based on multivariable Cox proportional hazard regression and were internally validated with bootstrapping. Performance was assessed by the concordance index and calibration plots. ResultsIn all, 8044 patients who underwent abdominal resection of colorectal cancer Stage I-III were included. The colon and rectal cancer risk score models predicted metachronous peritoneal carcinomatosis with a concordance index of 80% and 78%, respectively. Factors in the models included age, pathological pT stage, pN stage, number of examined lymph nodes (0-11, 12+), type of surgery (emergency/elective), completeness of cancer resection (R0/R1/R2), adjuvant chemotherapy (yes/no), preoperative radiotherapy and tumour location. ConclusionThe proposed predictive models showed high internal validity and enabled individualized prediction of peritoneal recurrence of colorectal cancer. The models may help in the planning of treatment and follow-up of patients. However, external validation is warranted to assess generalizability of the predicted absolute risks.
引用
收藏
页码:359 / 367
页数:9
相关论文
共 21 条
[1]   Patients at Risk for Peritoneal Surface Malignancy of Colorectal Cancer Origin: The Role of Second Look Laparotomy [J].
Bruecher, Bjoern L. D. M. ;
Stojadinovic, Alexander ;
Bilchik, Anton J. ;
Protic, Mladjan ;
Daumer, Martin ;
Nissan, Aviram ;
Avital, Itzhak .
JOURNAL OF CANCER, 2013, 4 (03) :262-269
[2]   Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer [J].
da Silva, Rodrigo Gomes ;
Sugarbaker, Paul H. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (06) :878-886
[3]   Peritoneal carcinomatosis from colorectal or appendiceal origin:: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement [J].
De Bree, E ;
Koops, W ;
Kröger, R ;
Van Ruth, S ;
Witkamp, AJ ;
Zoetmulder, FAN .
JOURNAL OF SURGICAL ONCOLOGY, 2004, 86 (02) :64-73
[4]   Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT [J].
Dromain, Clarisse ;
Leboulleux, Sophie ;
Auperin, Anne ;
Goere, Diane ;
Malka, David ;
Lumbroso, Jean ;
Schumberger, Martin ;
Sigal, Robert ;
Elias, Dominique .
ABDOMINAL IMAGING, 2008, 33 (01) :87-93
[5]   Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis [J].
Elias, D. ;
Honore, C. ;
Dumont, F. ;
Ducreux, M. ;
Boige, V. ;
Malka, D. ;
Burtin, P. ;
Dromain, C. ;
Goere, D. .
ANNALS OF SURGERY, 2011, 254 (02) :289-293
[6]   Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study [J].
Elias, Dominique ;
Gilly, Francois ;
Boutitie, Florent ;
Quenet, Francois ;
Bereder, Jean-Marc ;
Mansvelt, Baudouin ;
Lorimier, Gerard ;
Dube, Pierre ;
Glehen, Olivier .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :63-68
[7]   Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin [J].
Elias, Dominique ;
Lefevre, Jeremie H. ;
Chevalier, Julie ;
Brouquet, Antoine ;
Marchal, Frederic ;
Classe, Jean-Marc ;
Ferron, Gwenael ;
Guilloit, Jean-Marc ;
Meeus, Pierre ;
Goere, Diane ;
Bonastre, Julia .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) :681-685
[8]   Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion Versus Systemic Chemotherapy Alone for Colorectal Peritoneal Carcinomatosis [J].
Franko, Jan ;
Ibrahim, Zuhaib ;
Gusani, Niraj J. ;
Holtzman, Matthew P. ;
Bartlett, David L. ;
Zeh, Herbert J., III .
CANCER, 2010, 116 (16) :3756-3762
[9]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[10]  
2-4